Clarithromycin resistance in Helicobacter pylori infection: Does it matter?
Open Access
- 1 October 2000
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 15 (10) , 1089-1092
- https://doi.org/10.1046/j.1440-1746.2000.02362.x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South‐East AsiaAlimentary Pharmacology & Therapeutics, 2000
- Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strainsAlimentary Pharmacology & Therapeutics, 1999
- The effect of antibiotic resistance on the outcome of three 1‐week triple therapies against Helicobacter pyloriAlimentary Pharmacology & Therapeutics, 1999
- Prevalence ofHelicobacter pylori resistance to several antimicrobial agents in a region of GermanyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Antimicrobial resistance testing of Helicobacter pylori: A comparison of etest and disk diffusion methodsPathology, 1997
- One week triple therapy for Helicobacter pylori: a multicentre comparative studyGut, 1997
- Short‐course therapy with amoxycillin–clarithromycin triple therapy for 10 days (ACT‐10) eradicates Helicobacter pylori and heals duodenal ulcerAlimentary Pharmacology & Therapeutics, 1997
- Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.Gut, 1997
- Prevalence of primaryHelicobacter pylori resistance to metronidazole and clarithromycin in The NetherlandsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Randomized comparison of differing periods of twice‐a‐day triple therapy for the eradication of Helicobacter pyloriAlimentary Pharmacology & Therapeutics, 1996